- OverviewPress tab for submenu items
TCS is here to make a difference through technology.
Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
-
Industries
-
Services
-
Products and Platforms
-
Research & Innovation
Overview
Industries
expand here
Services
expand here
Products and Platforms
expand here
Research & Innovation
expand here
- OverviewPress tab for submenu items
We’re in it for good, driving positive change for the benefit of all.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
-
About Us
- OverviewPress tab for submenu items
Extraordinary expertise leads to remarkable results.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
-
Customer Stories
-
Perspectives
-
Global studies
-
Topics
- OverviewPress tab for submenu items
Want to be a global change-maker? Join our team.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
-
India
-
Americas
-
Asia Pacific
-
Europe and UK
-
Middle East and Africa
Overview
India
expand here
Americas
expand here
Asia Pacific
expand here
Europe and UK
expand here
Middle East and Africa
expand here
- OverviewPress tab for submenu items
Find the latest news about TCS in our Newsroom
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
-
Press releases
-
News alerts
-
Analyst recognition
Recent recognitions
View all -
Events
Upcoming events
08 Nov 2024 TCS BaNCS at CorpActions 2024, LondonView all29 Oct 2024 TCS at OpenText World 2024 -
Media kit
- OverviewPress tab for submenu items
TCS works hand in hand with world-leading investors.
Tata Consultancy Services LimitedNSE:TCSINR -
Management Commentary
-
Financials
-
News and Events
-
ESG
-
Resources
Overview
Management Commentary
expand here
Financials
expand here
News and Events
expand here
ESG
expand here
Resources
expand here
Top Results
Showing
10
01 - 07
You have these already downloaded
We have sent you a copy of the report to your email again.
New-age AI technologies and cognitive automation solutions can make the pharmacovigilance (PV) process faster, agile, consistent, accurate, compliant and more efficient. Even though there is no viable “one-size-fits-all” approach to adopting an AI-based PV solution, there is a consensus that technology is an imperative for transforming the PV approach for Life Sciences organizations. We believe the information gathered from our experience clearly presents benefits of AI on operational safety case processing and transformative impact on PV. This paper will guide you to:
- Leverage an AI-driven platform to increase productivity, improve product safety analysis, drive business growth, support in budgetary responsibility and bring innovation
- Realize a digital organization with performance excellence capabilities through enterprise agility and digital AI case processing
About the authors
Image of Dr. Alejandra Guerchicoff
Dr. Alejandra Guerchicoff
Dr. Alejandra Guerchicoff is a PhD in molecular genetics with a post-doctoral training in molecular cardiology. She is working as an Industry Advisor for TCS ADD platform with the Life Sciences unit at Tata Consultancy Services (TCS). Dr. Guerchicoff possesses a rich experience of more than 20 years in the domain of clinical research and post-marketing pharmacovigilance, for medical devices, drugs, combination products, gene and cell therapy, and software as medical device products.
Image of Michael Murphy
Michael Murphy
Michael D. Murphy leads the PV Operations team within Global Patient Safety at Amgen, a position he has held since April 2019. Responsibilities include overseeing and managing teams accountable for adverse event case processing and medical review, periodic reporting, safety reporting obligations for clinical, commercial/marketing programs, and oversight of the safety technologies.
Related reading
1/4
Alejandra Guerchicoff
Next-gen Medical Writing: The Current State and Future Perspective
White Paper
|
10 Jul 2024
Opens in new tab
2/4
Alejandra Guerchicoff
Transforming PV Efficiencies with ML and Rule-based Automation
White Paper
|
18 Aug 2023
Opens in new tab
3/4
Alejandra Guerchicoff
The new age digital contract research organizations
White Paper
|
23 Dec 2022
Opens in new tab
4/4
Alejandra Guerchicoff
A hybrid approach towards signal management in Pharmacovigilance
White Paper
|
22 Dec 2022
Opens in new tab
Transformation starts here
Learn how we can help you bring drugs to the market faster.
Talk to our expertsFind out more
©2024 TATA Consultancy Services Limited
©2024 TATA Consultancy Services Limited
- Privacy Notice
- Cookie Policy
- Disclaimer
- Security Policy
- California Notice at Collection
- Customize Cookies
What’s on your mind?
We’re here to help! Tell us what you’re looking for and we’ll get you connected to the right people.
Looking for something else?